Compiled by IPRO HQIC
The following are websites where you can resources related to Opioid Stigma:
- CDC. “Patients’ Frequently Asked Questions | CDC’s Response to the Opioid Overdose Epidemic | CDC.” Www.cdc.gov, 19 Oct. 2021, www.cdc.gov/opioids/patients/faq.html. Spanish Language version available here.
- CDC. “Stigma Reduction.” Www.cdc.gov, 25 July 2023, www.cdc.gov/stopoverdose/stigma/index.html. Accessed 10 Oct. 2023.
- IPRO HQIC. “Naloxone Saves Lives – HQIC Resource Library.” IPRO HQIC Resource Library, 20 Sept. 2022, hqic-library.ipro.org/2022/09/20/naloxone-saves-lives/. Accessed 10 Oct. 2023. Spanish language version available here.
- IPRO HQIC. “People Matter, Words Matter – IPRO QIN-QIO Resource Library.” IPRO HQIC Resource Library, 28 July 2023, qi-library.ipro.org/2023/07/28/people-matter-words-matter/. Accessed 10 Oct. 2023.
- Where Opioid Use Disorder Stigma Comes From and How to Prevent It Opioid Use Disorder Stigma: Causes, Impact, Prevention (healthline.com)
- 4 Factors That Add to Stigma Surrounding Opioid Use Disorder 4 factors that add to stigma surrounding opioid-use disorder | American Medical Association (ama-assn.org)
- Stop Overdose: Stigma Reduction Stigma Reduction (cdc.gov) (PDF flyer REDUCING STIGMA (cdc.gov))
- The stigma that undermines care The stigma that undermines care (apa.org)
- Stigma: Overcoming a Barrier to Pain Treatment and Addiction Recovery Stigma: Overcoming a Barrier to Pain Treatment and Addiction Recovery | NIH HEAL Initiative
- Substance Use Disorder Stigma: What it is and How You Can Prevent it Substance Use Disorder Stigma: What it is and How You Can Prevent it | USU
- Punishing Drug Use Heightens the Stigma of Addiction Punishing Drug Use Heightens the Stigma of Addiction | National Institute on Drug Abuse (NIDA) (nih.gov)
- Medical Stigma and Patients with Substance Abuse Disorder Medical Stigma and Patients with Substance Abuse Disorders | Psychology Today
- Panel Discussion: Stigma Around Opioid Use Disorder Presents Challenges to Treatment Stigma Around Opioid Use Disorder Presents Challenges to Treatment | The Pew Charitable Trusts (pewtrusts.org)
- Stigma of opioids a hurdle to solving crisis Stigma of opioids keeps users from seeking help, taints views of medical professionals – Harvard Gazette
- Why Opioid Addiction Should Be Viewed-And Treated-Like a Chronic Disease Opioid Use Disorder: Managing Stigma & Treatment | The Well by Northwell
- Part 1: Guiding Principles for Addressing the Stigma on Opioid Addiction Guiding Principles for Addressing the Stigma on Opioid Addiction | Bloomberg American Health Initiative (jhu.edu)
- Part 2: A Roadmap to Reduce Stigma on Opioid Addiction A Roadmap to Reduce Stigma on Opioid Addiction | Bloomberg American Health Initiative (jhu.edu)
- Confronting the Stigma of Opioid Use Disorder- and Its Treatment Confronting the Stigma of Opioid Use Disorder—and Its Treatment | Substance Use and Addiction Medicine | JAMA | JAMA Network
- Social Stigma Toward Persons with Prescription Opioid Use Disorder: Associations With Public Support for Punitive and Public Health-Oriented Policies Social Stigma Toward Persons With Prescription Opioid Use Disorder: Associations With Public Support for Punitive and Public Health–Oriented Policies | Psychiatric Services (psychiatryonline.org)
- Portraying mental illness and drug addiction as treatable health conditions: Effects of a randomized experiment on stigma and discrimination Portraying mental illness and drug addiction as treatable health conditions: Effects of a randomized experiment on stigma and discrimination – ScienceDirect
- The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy – PubMed (nih.gov)
- Stigma, discrimination and the health of illicit drug users Stigma, discrimination and the health of illicit drug users – PubMed (nih.gov)
- The role of stigma in U.S. primary care physicians’ treatment of opioid use disorder The role of stigma in U.S. primary care physicians’ treatment of opioid use disorder – ScienceDirect
- Addressing Bias and Stigma in the Language We Use With Persons With Opioid Use Disorder: A Narrative Review Addressing Bias and Stigma in the Language We Use With Persons With Opioid Use Disorder: A Narrative Review – PubMed (nih.gov)
- Opioid use-related stigma and healthcare decision-making Opioid use-related stigma and health care decision-making – PubMed (nih.gov)
Prepared by IPRO
Buprenorphine for Pain: A Transition Guide from Full Agonist Opioid Prescriptions is a tool intended to aid clinicians in switching patients off of full opioid agonists to buprenorphine, a partial mixed opioid agonist for pain management.
The information presented in this document should not be considered medical advice and is not a substitute for individualized patient or client care and treatment decisions.
Prepared by IPRO
The Buprenorphine Resource Guide is a resource that contains the various FDA-approved formulations of buprenorphine for Opioid Use Disorder and pain management. This resource guide also includes a brief history of buprenorphine and explains its analgesic effects.
Prepared by IPRO
Join us for this special presentation featuring real-world strategies for preventing hospital delirium! Delirium affects as many as 50% of hospitalized patients over the age of 65. Furthermore, delirium accounts for increased length of stay, hospital readmissions, emergency department visits and institutionalization of older adults. Delirium is often precipitated by opioid use for pain management. Don’t miss this discussion on alternatives, using an example of a successful hospital project. These initiatives will inspire you to take on delirium prevention at your facility!
Prepared by Anne Myrka, RPh, MAT, IPRO
This patient education document describes what Naloxone is, how it works, why it is offered to individuals with an opioid prescription, and signs of opioid overdose.
Spanish language version available here.
Prepared by IPRO NQIIC
Conversation Starter to assist clinicians in counseling patients on the use of opioid medication prior to discharge, in the ER or in the clinic setting.
Prepared by IPRO QIN-QIO, Centers for Medicare & Medicaid Services Quality Improvement & Innovation Group
Use with Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain document and the Opioid and Pain Management Best Practice Aggregate Results Dashboard.
Centers for Disease Control and Prevention
The NHSN application provides various options that allow NHSN users to analyze their surveillance data. The resources listed on the link above are intended to help you use the analysis tool, and interpret data analyzed from the Patient Safety Component of NHSN.
Centers for Disease Control and Prevention (CDC)
This interactive, web-based training features self-paced learning, case-based content, knowledge checks, and integrated resources to help healthcare providers gain a deeper understanding of the CDC Guideline for Prescribing Opioids for Chronic Pain. Find tips on implementing the Guideline in primary care practice and overcoming challenges. Earn free CE.
Center for Disease Control and Prevention (CDC)
Clinical practice guidelines encourage use of the PDMP prior to prescribing to assess a patient’s history of controlled substance use. It is possible to improve the way opioids are prescribed, reducing the number of people who misuse, abuse, or overdose from them, while making sure patients have access to safe, effective pain management. A prescription drug monitoring program (PDMP) is an electronic database that tracks controlled substance prescriptions. PDMPs can help identify patients who may be misusing prescription opioids or other prescription drugs and who may be at risk for overdose.
IPRO Hospital Quality Improvement (HQIC), Learning and Action Network (LAN) webinar on the All-Cause Harm focus are of Opioid Stewardship: April 26th 2021.
IPRO HQIC presented aggregate baseline data on the Opioid Stewardship Hospital Baseline Assessment and heard from a rural hospital on promoting the safe use of opioids (prescribing policy, scripted communication tools, alternatives to opioids, tracking prescribing practices, referral network for pain management, and MAT therapy).
In addition, IPRO HQIC highlight many salient opioid stewardship resources on processes that support the inclusion of patient and family engagement and health equity (stigma) in opioid stewardship efforts. These resources further support IPRO HQIC hospital efforts in All-Cause Harm reduction.
Recording, Slides and All-Cause Harm Resource available.
Health and Human Services (HHS) April, 2021
In an effort to get evidenced-based treatment to more Americans with opioid use disorder, the Department of Health and Human Services (HHS) is releasing new buprenorphine practice guidelines that among other things, remove a longtime requirement tied to training, which some practitioners have cited as a barrier to treating more people.
Signed by HHS Secretary Xavier Becerra, the Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder exempt eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists and certified nurse midwives from federal certification requirements related to training, counseling and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine.